Prolongation of the Disease-Free Interval in Surgically Treated Rectal Carcinoma

New England Journal of Medicine

Volumn 312, Issue 23, 1985, Pages 1465-1472

 

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; SEMUSTINE;

CANCER RECURRENCE; CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; LARGE INTESTINE; MAJOR CLINICAL STUDY; POSTOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTUM CARCINOMA; SURVIVAL; THERAPY; TUMOR;

ADENOCARCINOMA; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMAN; MALE; MIDDLE AGE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RANDOM ALLOCATION; RECTAL NEOPLASMS; SEMUSTINE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0021792174     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198506063122301     Document Type: Article

References (18)

1. Silverberg E. Cancer statistics, 1985. CA 1985; 35: 19–35.
2. Dukes C, ed. Cancer of the rectum. Baltimore: Williams & Wilkins, 1960:59–68.
3. Gunderson LL, Sosin H. Areas of failure found at reoperation (second or symptomatic look) following “curative surgery” for adenocarcinoma of the rectum: clinicopathologic correlation and implications for adjuvant therapy. Cancer 1974; 34: 1278–92.
4. Carter SK. 5-Fluorouracil as adjuvant chemotherapy for large bowel cancer: is it appropriate for routine community use? Cancer Chemother Pharmacol 1979; 2: 81–4.
5. Lawrence W Jr. Adjuvant therapies for colo-rectal cancer: do they improve the results obtained by surgical resection? Surg Rounds 1979; 2(10):54–60.
6. Rider WD, Palmer JA, Mahoney LJ, Robertson CT. Preoperative irradiation in operable cancer of the rectum. Can J Surg 1977; 20: 335–8.
7. Higgins GA Jr, Conn JH, Jordon PH Jr, Humphrey EH, Roswit B, Keehn RJ. Preoperative radiotherapy for colorectal cancer. Ann Surg 1975; 181: 624–31.
8. Steams MW Jr, Deddish MR, Quan SHQ, Leaming RH. Preoperative roentgen therapy for cancer of the rectum and rectosigmoid. Surg Gynecol Obstet 1974; 138: 584–6.
9. Higgins GA Jr, Lee L, Dwight R, Keehn RJ. The case for adjuvant 5-fluorouracil in colorectal cancer. Cancer Clin Trials 1978; 1: 35–41.
10. Grage TB, Moss SE. Adjuvant chemotherapy in cancer of the colon and rectum: demonstration of effectiveness of prolonged 5-FU chemotherapy in a prospectively controlled, randomized trial. Surg Clin North Am 1981; 61: 1321–9.
11. Baker LH, Talley RW, Matter R, et al. Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU versus methyl-CCNU plus bolus weekly 5-FU: a Southwest Oncology Group Study. Cancer 1976; 38: 1–7.
12. Posey LE, Morgan LR. Methyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel. Cancer Treat Rep 1977; 61: 1453–8.
13. Moertel C, Schutt AJ, Hahn RG, Reitemeier RJ. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3 cis(2-chlorethyl)-1-nitrosourea, and vincristine. JNCI 1975; 54: 69–71.
14. Moertel CG, Childs DS Jr, Reitemeier RJ, Colby MY Jr, Holbrook MA. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969; 2: 865–7.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81.
16. Cox DR. Regression models and life tables. J R Stat Soc [B] 1972; 34: 187–220.
17. Boice JD Jr, Greene MH, Killen JY Jr, et al. Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU). N Engl J Med 1983; 309: 1079–84.
18. Gastrointestinal Tumor Study Group. Adjuvant therapy of colon cancer: results of a prospectively randomized trial. N Engl J Med 1984; 310: 737–43.